News
-
John P. Richie, Jr., Ph.D. Sets the Record Straight About Glutathione
February 27, 2009 New York, NY – John P. Richie, Jr., Ph.D. will present Setria® Glutathione - the Power to Protect at Supply Expo/Expo West on Saturday, March 7.
-
Makoto Yagasaki to Speak About New Fermentology Breakthroughs
February 24, 2009 New York, NY – Kyowa Hakko was the first company to develop amino acids using fermentation technology. On Wednesday, March 4 at Nutracon, Makoto Yagasaki, Ph.D. will be one of the featured speakers discussing New Fermentology Breakthroughs.
-
Kyowa Hakko USA Is New Distributor of Daiichi Fine Chemical Co.
January 22, 2009 New York, NY – Kyowa Hakko USA has announced it is the new distributor of Daiichi Fine Chemical Co., Ltd. (DFK) vitamins and other fine chemical products.
-
John P. Richie, Jr., Ph.D. to Speak at SupplySide West
October 21, 2008 New York, NY – John P. Richie, Jr., Ph.D., professor of Public Health Sciences and Pharmacology Cancer Institute at Penn State University School of Medicine, will be the featured speaker discussing the latest scientific discoveries about the breach between food intake and need for Glutathione dietary supplementation, at the Kyowa Hakko USA VendorWorks seminar at SupplySide West. The seminar will be held on Friday, October 24, 10 to 10:50 a.m. in the Galileo Room #901 at the Sands Convention Center in Las Vegas. Glutathione, a tri-peptide composed of glutamic acid, cysteine ...
-
Healthy Origins® Introduces Two New Products with Setria®
October 20, 2008 New York, NY – Kyowa Hakko USA has announced that Healthy Origins® has launched two new products formulated with the Setria® brand of L-Glutathione. Healthy Origins® Setria® L-Glutathione Reduced 250mg and 500mg potencies will be available at health food stores in 60 capsule bottles. Setria® L-Glutathione is a tri-peptide, made from glutamic acid, cysteine, and glycine. As the master antioxidant of the cell, Glutathione increases the effectiveness of the body's other antioxidants like Vitamin C and E and is involved in various reactions, such as the destruction of free rad...
-
Kyowa Hakko Completes GRAS for Sustamine™
September 17, 2008 New York, NY – Kyowa Hakko has announced it has completed GRAS (generally recognized as safe) self-affirmation for its dipeptide Sustamine™ L-Alanyl-L- Glutamine. According to Yoichiro Sugimura, Kyowa Hakko USA senior director of scientific affairs and business development, Sustamine™ L-Alanyl-L-Glutamine is a "high-tech" amino acid dipeptide that promotes muscle rehydration, recovery and can be used as a source for energy refueling. Sustamine™ L-Alanyl-L-Glutamine is produced by a novel and cost-effective patented fermentation technology. Sustamine™ is available in po...
-
Kyowa Hakko to Present New Science on Skincare
September 11, 2008 New York, NY – Yoichiro Sugimura, senior director of scientific affairs and business development for Kyowa Hakko USA, will be one of the featured speakers at the New Natural/Organic Ingredients Conference and Expo at the New York Hilton Hotel, Wednesday, October 22. Sugimura’s presentation, scheduled to begin at 11:55 a.m. is entitled, New Amino Acid Technology to Enhance Collagen Synthesis. Ride the Next Natural/organic Wave Ingredient and Technology Conference and Exhibition focuses on anti-aging, skincare and special skin needs. Sugimura, one of the industry’s intern...
-
Alliance Formed Between Kyowa U.S.A. and Austin Chemical Co.
July 2, 2008 New York, NY – Kyowa Hakko U.S.A., Inc. and Austin Chemical Company, Inc. have formed an alliance for Austin Chemical to market and sell Kyowa Hakko-produced Sustamine™ L-Alanyl-L-Glutamine in the United States and Canada for cell culture media end uses.
-
Debra Berman Joins Kyowa Hakko USA
April 17, 2008 New York, NY – Kyowa Hakko USA has announced that Debra Berman has joined the New York office of Kyowa Hakko USA as sales director for the southeast US region.
-
CBS-TV News Feature on Cognizin®
April 14, 2008 New York, NY – A report by WBZ-TV, the CBS-TV affiliate in Boston, focusing on the most recent Cognizin Citicoline study, is being distributed to all CBS-TV news affiliates nationwide.